Survival benefits of Cytoreductive Nephrectomy in patients with metastatic renal cell carcinoma: evidence from a SEER-based retrospective cohort study. [PDF]
Peng X +5 more
europepmc +1 more source
Revisiting Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma: Real-World Evidence of Survival Benefit with First-Line Immunotherapy and Targeted Therapy Regimens. [PDF]
Manivasagam SS, Aminsharifi A, Raman JD.
europepmc +1 more source
Rethinking lymph node metastasis and cytoreductive nephrectomy
openaire +3 more sources
Immune checkpoint inhibitor therapy in metastatic renal cell carcinoma: tumour response and immune-related renal vasculitis following cytoreductive nephrectomy. [PDF]
Jain E +4 more
europepmc +1 more source
Can Cytoreductive Nephrectomy Improve Outcomes of Nivolumab Treatment in Patients with Metastatic Clear-Cell Renal Carcinoma? [PDF]
Ocak B +29 more
europepmc +1 more source
Impact of Preoperative Systemic Therapy on Cytoreductive Nephrectomy Outcomes in the National Surgical Quality Improvement Program (NSQIP). [PDF]
Dason S +10 more
europepmc +1 more source
Case Report: Cytoreductive nephrectomy and thrombectomy in metastatic renal cell carcinoma with venous tumor thrombus: a case using indocyanine green fluorescence-guided laparoscopy. [PDF]
Dong X, Zhang J, Pan Y, Xie T, Wang J.
europepmc +1 more source
The role of cytoreductive nephrectomy in metastatic renal cell carcinoma in the modern era. [PDF]
Galarza Fortuna GM, Maughan BL.
europepmc +1 more source
Assessing the survival advantage of deferred cytoreductive nephrectomy using a prediction interval. [PDF]
Hung KC, Tsai IT, Sun CK.
europepmc +1 more source

